Shares of Invitae Co. (NYSE:NVTA – Free Report) have been given a consensus recommendation of “Reduce” by the eleven analysts that are currently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a sell rating and six have issued a hold rating on the company. The average 12 month target […]
Swiss National Bank increased its holdings in Invitae Co. (NYSE:NVTA – Get Rating) by 4.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 539,600 shares of the medical research company’s stock after buying an additional 23,100 shares during […]
Mirae Asset Global Investments Co. Ltd. decreased its position in shares of Invitae Co. (NYSE:NVTA – Get Rating) by 21.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,415,682 shares of the medical research company’s stock after selling 391,747 shares during the period. […]
StockNews.com initiated coverage on shares of Invitae (NYSE:NVTA – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a sell rating on the medical research company’s stock. Several other research analysts also recently issued reports on NVTA. The Goldman Sachs Group downgraded shares of Invitae from a neutral rating […]
Stock analysts at StockNews.com assumed coverage on shares of Invitae (NYSE:NVTA – Get Rating) in a research note issued on Thursday. The firm set a “sell” rating on the medical research company’s stock. A number of other research analysts also recently commented on the company. The Goldman Sachs Group downgraded Invitae from a “neutral” rating […]